DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kovacs MJ, Levine MN, Keeney M. et al.
Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients.
Thromb Haemost 2005;
93: 1185-1188.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.